Competition & Peer Data API & CSV Delivery

Wright Medical Group N V's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Wright Medical Group N V (WMGI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2020
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
5.15 %
Q3 2020
Net Margin
-8.83 %
Q3 2020

Key Findings: Wright Medical Group N V vs Its Competitors

  • TTM: Trailing 12-month revenue of 313M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+185.5% annualized vs trailing 12 months).
  • Peer revenue share: Wright Medical Group N V accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

WMGI Sales vs. its Competitors, Q3 2020

Wright Medical Group N V generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/WMGI/competitors
https://api.csimarket.com/api/v1/companies/WMGI/relationships
https://api.csimarket.com/api/v1/companies/WMGI/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs 5.2% for Wright Medical Group N V. Wright Medical Group N V's share of combined industry revenue moved from 0.21% to 0.19%, a loss of 0.02 percentage points.

Wright Medical Group N V's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Wright Medical Group N v No Yes Yes No
Similar Growth & Profitability (8) 25.00 % (2 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 25.00 % (2 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2020

100%market share
  • Wright Medical Group N V100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Wright Medical Group N V and its 0 tracked competitors.

See Wright Medical Group N V's full market share breakdown »

WMGI Stock Performance relative to its Competitors

WMGI Competitors (weighted) Percent change over the selected range

WMGI Stock Performance relative to Similar Growth & Profitability Competitors

WMGI Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Wright Medical Group N V's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Wright Medical Group N v Upper Extremities 39.72 % Lower Extremities Biologics 29.75 % Extremities Biologics 9.89 %

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).